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ABSTRACT 
 Background: Obesity is a health emergency growing worldwide. The hallmark of 
obesity is an augment in visceral fat. Alongside waist circumference gain, impaired blood 
lipid profile and hypertension it leads to Metabolic Syndrome (MetS). Amongst the 
several factors contributing to its spread, breakfast consumption plays a role promoting 
ghrelin regulation. In addition, breakfast consumption may ameliorate cognitive 
performance. 
 Aim: We focused on how three different commercial breakfasts, with different 
contents of macronutrients, affected: 1) metabolic response and sense of satiety via 
ghrelin regulation (protocol M); 2) cognitive processing of sensory information via P300 
recording (protocol N). To our purposes, we administered three different commercial 
breakfasts and glucose, as control, to 12 healthy subjects (6M/6F; 22.2±1.5 Kg/m2; 27±5 
yo) who underwent two different experimental protocols to assess aim 1 and 2. Aside 
control (A 50gr glucose) The commercial breakfasts were as follows: B1) milk (125mL) 
and cornflakes (30gr); B2) milk (220mL), apple (200gr) and chocolate cream filled 
sponge cake (30gr) and B3) milk (125mL), apple (150gr), bread (50gr) and hazelnut-
chocolate cream (15gr). 
 Protocol M: each subject went through one Oral Glucose Tolerance Test (50gr-
OGTT) and three-meal test loads (one for each tested breakfast). We collected blood 
samples at -15’; 0; 15’; 30’; 45’; 60’; 75’; 90’ and 120’. Volunteers ate breakfast after the 
second blood sampling. We assayed glucose, insulin and ghrelin plasma levels (total). 
 Protocol N: in four different days, each subject underwent eight evoked related 
potentials measurement (ERPs), two for each breakfast (one after a night fast and one 
three hours after breakfast consumption). To our purposes, we recorded frontal zone (FZ) 
ERPs latencies.  
 Results: metabolic data showed that all three commercial breakfasts gave a 
significant lower glycemic response when compared to glucose (B1: p=<0.05; B2, B3: 
p<0.01) alongside a lower insulin response (only breakfasts B1 and B2 in a significant 
fashion: p<0.01). Ghrelinemia inhibition tended to be greater in B3 group (332.1±30.2 
pg/mL) with respect to A (420.6±44.2 pg/mL), but did not achieve statistical significance. 
Electrophysiological data showed that, three hours after ingestion, B1, B2 and B3 
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displayed a decrease in FZ ERPs latency when respect to A, thus only B3 in a significant 
way (p<0.01). 
 Conclusion: we demonstrated that different breakfasts were able to elicit lower 
glycemic and insulin responses even with a greater carbohydrate content. B1, B2 and B3 
groups displayed a tendency to maintain satiety via ghrelin inhibition. Furthermore, 
hazelnut-chocolate cream breakfast (B3) consumption decreased P300 latency, 
suggesting ameliorated cognitive performance.  
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1. INTRODUCTION 
 A diet rich in high glycemic index foods is associated with a major risk of 
developing obesity and type 2 diabetes mellitus (T2DM). During the last 20 years, obesity 
and overweight incidence rose both in adult and in pediatric population. This tendency, 
spread from developed to developing countries leading to a world pandemic emergency 
so that, according to WHO data, obesity is responsible for at least 2.8 million deaths/year 
[1]. 
A Body Mass Index (BMI) greater or equal to 30 Kg /m2 defines pathologic obesity in 
adults [2]. Increased BMI, alongside with augmented visceral fat, waist circumference 
gain, dyslipidemia and hypertension characterizes the Metabolic Syndrome (MetS) which 
is the major risk factor of one of the leading causes of death: cardiovascular diseases 
(CVDs). Obesity relates both to CVDs development and to overt T2DM. It is common to 
refer to diabetes and obesity as “diabesity”, to mark further the liaison between the two 
diseases [3].  
Spread and incidence augment of obesity and T2DM are, in fact, parallel and both 
diseases show defects in insulin action (sensitivity and secretion). The molecular 
mechanisms that link obesity to diabetes are mainly due to the increased plasma Free 
Fatty Acids (FFA) levels typical of MetS. The higher amount of these molecules found 
in obese and overweight patients is due mainly to the particular food intake of this 
individuals and the augmented lipolysis activity [3].  
It is known that adipose tissue is more active in overweight and obese subjects than 
healthy ones [3]. This augmented activity leads to increased FFAs levels. The subsequent 
augment in mitochondrial β-oxidation is able to interrupt glucose metabolism and to 
reduce its uptake and glycogen synthesis from the skeletal muscle. The constant state of 
hyperglycemia and the compensatory hyperinsulinemic effort by pancreas impair insulin 
sensitivity. This phenomenon, commonly referred as “glucotoxicity”, leads to glycation 
of proteins and the synthesis of advanced glycation end products, which may induce β-
cell failure in secreting insulin and final stage of this exposure is β-cell apoptosis. 
Furthermore, when fat intake from dietary habits increases, fat storage occurs in liver, 
skeletal muscle and β-cells. Since it is not common for these tissues to store high fat 
amounts, the excessive mitochondrial production of toxic reactive lipid species speeds up 
insulin resistance and impaired glucose metabolism. This leads, with time, to overt type 
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two diabetes mellitus. The liaison between obesity and diabetes is so strong that 90% of 
T2DM patients are also obese [4].  
Overweight and obesity management costs, their comorbidities and social reflections led 
local authorities to develop new strategies to fight these diseases. However, despite 
efforts, knowledge on obesity pathophysiology is incomplete and a control on obesity 
incidence is still far. According to a survey from Eurostat, overweight and obesity occur 
in almost every Member State in European Union both in female and male population 
with rates that span between 37-56.7% and 51-69.3%, respectively. These obese subjects 
develop the above-mentioned typical features of MetS, which may lead to T2DM, CVDs, 
hypertension and some types of cancer [5].  
Since MetS is associated with several and severe diseases, it is important to make efforts 
to prevent it, especially at young age. 
MetS settles thanks to more than a few factors: social behavior, environment, genetic and 
metabolic features and physical inactivity. The range of cofactors responsible for 
overweight, obesity and MetS is so wide that even gut micro biome plays a role in these 
diseases onset [6]. This large pool of factors reflects the several therapeutic approaches 
to treat this condition: life-style modifications, diet, surgical interventions, counselling 
and so on.  
As long as regarding alimentary behavior, excessive or imbalanced food intake leads to a 
disproportion in introduced/consumed energy equilibrium, causing visceral fat 
deposition. For these reasons, physicians intervened on diet and life-style in order to make 
energy balance healthy again for patients displaying MetS. However, an aspect 
concerning food, which received more and more attention during these years, exists: i.e. 
the effects of specific nutrients presents in food on pathophysiological and physiological 
events. Combined with meal caloric composition and nutritional facts, “eating patterns” 
affect gain weight. “Eating patterns” include food intake habits e.g.: frequency of meals 
and snack consumption [7].  
Regular ingestion of meals helps preventing obesity predisposition and settling. Amongst 
the different meals of the day, breakfast plays a major role in energy homeostasis with its 
contribution both in caloric and nutrient intake [8]. A variety of studies conducted both 
in Western and Eastern countries report that breakfast skipping is associated with weight 
gain and obesity [8]. What is interesting is that these studies allow to state that the 
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association between breakfast skipping and weight gain is true regardless the existence 
of several factors that contribute to overweight and obesity, such as social, cultural and 
economic background. 
This phenomenon may find explanation in the lack of satiety during the day and the 
following increased energy intake. Furthermore, a difference in post-prandial insulin 
levels subsists amongst the different eating patterns regarding breakfast consumption 
habits. People having breakfast regularly and people who skip it on a daily basis do not 
share the same post-prandial insulin levels. In fact, the latter category displays a higher 
insulin secretion after meal ingestion. In this condition, insulin may help fat storage [9].     
Breakfast skipping is an insalubrious dietary habit in healthy individuals, obese patients 
and especially in children and adolescents. This use in the two latter classes associates to 
obesity predisposition and it is one of the causes of MetS incidence augment, a dramatic 
condition at young age that may affects development, social life and school achievements 
[8]. Indeed, the importance of breakfast relates not only to overweight and obese 
predisposition. Another aspect, which relates to all age classes, and better to children and 
adolescents, is that breakfast consumption helps cognitive functions [10-11]. 
Benton et al report that missing breakfast negatively influences memory [12-13]. This 
effect is reversed by glucose consumption. Even if the positive effect of glucose ingestion 
is powerful, it is too rapid to have a practical and prolonged influence on memory during 
morning. On the other hand, foods slowly releasing carbohydrates improve attention in 
late morning hours [14]. 
To stress out more the importance of breakfast at early age, evidences exist that first meal 
consumption improves attendance and level of achievements reached by students [12-13]. 
This is partly due to the known evidence that children need more glucose than adults do. 
In fact, starting from 4 years old glucose need in a child brain grows until it reaches a 
peak around 9 years old of age in which the need is four-fold higher. This condition 
decreases until 16-18 years old [15-16]. 
Neuronal effects of different breakfasts may vary because of the different macronutrients 
composition and those macronutrients relates to children behavior during school stay. 
Additionally, malnourished children seem to benefit from lower effects of breakfast 
consumption, as regarding attention issues [17].  
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Taken all together, these data show that breakfast consumption is important for at least 
two aspects: a better control on body weight and ameliorate attention, especially in 
children and adolescents. Furthermore, many children and adolescent present of skipping 
breakfast just because they do not want to do it. This population is more likely to be more 
physical inactive and to have a lower cardio respiratory fitness level. [18] 
In this study, we focused on the above-mentioned two important aspects of breakfast 
consumption: satiety regulation and cognitive processing of sensory information. We 
investigated how breakfast consumption may affect satiety via ghrelin inhibition and its 
impact on cognitive processing on healthy, young individuals via P300 recording. 
Ghrelin, hormone mainly secreted by X/A cells in the stomach, shows several 
physiological activities. Amongst these, ghrelin has a role in sense of satiety and food 
carving behavior.  P300 belongs to the Evoked related brain potentials (ERPs) 
waveforms. These scalp neural manifestations are widely used to assess cognitive 
performance. The reasons that led us to measure ghrelin inhibition as a biomarker of 
satiety and P300 recording as marker of cognitive performance are explained further in 
this thesis. 
With this in mind, we administered three commercially available breakfasts to 12 healthy, 
young volunteers, evaluated their metabolic and neural responses and compared them 
with our control, identified as 50gr of glucose. 
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1.1 Ghrelin 
 Ghrelin is a peptide hormone first described in 1999 by Kolima et al [19]. Its 
principal functions regard food intake and meal initiation. The X/A like cells in stomach 
mainly secretes ghrelin. These cells are copious in the oxyntic mucosa, particularly 
frequent in the gastric fundus and their number decreases ascending to the pylorus. 
Pancreatic islet cells display ghrelin and its receptors too, as part of evidence of its 
function in regulating glucose homeostasis but literature shows discrepancies about this 
feature [20]. 
Instead, a strong evidence in published studies suggest a role of ghrelin as energy storing 
promoter. In fact, ghrelin plasma levels augment before a meal intake and after a long 
period of negative energy balance (i.e.: a state in which the energy consumed is higher 
than the energy introduced via alimentation) [21-22]. As an example of this evidence: 
subjects suffering from anorexia nervosa display higher levels of plasma ghrelin when 
compared to subjects with a normal Body Mass Index (BMI) [23]. Vice versa, in obese 
patients ghrelinemia is lower but does not show down regulation after food intake [24], 
which should be ghrelin usual pattern after food consumption [25]. 
Ghrelin physiological actions stress out the “energy storing promoter” hypothesis since, 
in addiction to meal initiation properties, ghrelin is also responsible for igniting research 
of food behavior. The hormone stimulates craving for a particular quality of food eaten: 
studies have shown that high ghrelin plasma levels augment the intake of food rich in fats 
and energy density [26]. In addition to high fat and energy content food craving, ghrelin 
promotes adipogenesis, lipogenesis and the usage of other nutrients as energy substrates 
rather than lipids [27]. Furthermore, ghrelin is able to induce gastric acid and digestive 
enzymes secretion and to promote bowel movements thus easing nutrients absorption and 
strengthening its function as energy storage promoter [28].  
 After secretion, ghrelin is rapidly acylated in its active form (acylated-ghrelin) and 
systemically reaches the brain and its target cells: the neurons in arcuate nucleus 
expressing ghrelin receptor, GHSR1a [29]. After GHSR1a binding, intracellular calcium 
rapidly increases, thus activating calmodulin kinase-kinase 2 (CaMKK2), which in turn 
starts a phospholiration cascade leading to neuropeptide Y and agouti-related protein 
(NPY and AgRP) transcription [30]. Further details of ghrelin actions after binding to 
GHSR1a receptor are described in figure 1.1a. 
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Due to the functions ghrelin exerts on energy homeostasis (triggering food craving, high-
energy content foods ingestion and fat storage), research focused more and more on 
ghrelin and its possible implications in obesity treatment. For these reasons, we 
introduced ghrelin measurement in study design, in order to clarify better the role of 
different tested breakfasts’ consumption in satiety regulation.     
 
 
Figure 1.1a: schematic representation of ghrelin molecular mechanisms in cells expressing GHSR1a. CaMMK2: calciomodulin 
kinase-kinase 2; +P: phosphorylation; AMPK: adenosine monophosphate-activated protein kinase; ACC: acetyl coenzyme A 
carboxylase; CPT 1: carnitine-palmitoyltransferase-1; ROS: reactive oxygen species; UCP2: uncoupling protein-2; NPY: 
neuropeptide Y; AgRP: Agouti-related protein.  
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1.2 P300 Event Related Brain Potentials 
 Mechanisms of evolution developed the ability to drive proper reactions to external 
stimuli by telling apart amongst what is novel or unexpected and what is not. In this way, 
we are able to generate a natural and quick response to what could be a possible danger. 
Event-related brain potentials (ERP) are scalp manifestations of neural activity and reflect 
this shift of attention focus caused by the influence of certain events on consciousness 
[31]. Sutton et al. first described these modifications in electroencephalogram voltage in 
1965 [32]. This particular waveform latency peak is between 250ms and 350ms, so the 
event-related potential generated is usually referred as P300 or P3. This text refers to it 
as P300. 
 Since its finding, P300 was used to monitor and assess cognitive performance. P300 
recording became a widely used test to evaluate this feature and several recording 
techniques relate to new stimulus response: e.g.: skin conductance, pupillary dilatation, 
scalp or intracranial recorded and magnetic resonance imaging (MRI). After discovery, 
this safe protocol has been tested on children, elderly and brain-damaged patients [33- 
34]. 
The detachment between “danger” and “no danger” after an exposure to an external 
stimulus relates to context. David Friedman et al [35] wrote a reference that gives a simple 
and clearly understandable example involving an everyday life situation: a car driver and 
a pedestrian perceive car honks in a different way, which elicit different reactions. In fact, 
while driving it is usually common to listen to external noises (e.g.: music or engine 
sound) in background but, if a new or unexpected sound is heard (a car horn) the attention 
will shift to the source of the new sound, thus generating an orienting response. The latter, 
defined as a rapid, involuntary shift of attention, appears to be necessary for survival [36-
37]. Orienting is rapid and allows the subject to become aware of a possibly dangerous 
situation and to activate particular behaviors. As an evidence of the biological 
significance of this response, three months old babies orient their attention when exposed 
to the onset of a female voice [38]. 
ERPs are electrical activity manifestations generated by neuronal activation localized in 
different scalp regions and their name, event-related, clearly identifies their nature since 
these potentials are elicited by specific events. Their biological function is to orient the 
subject’s awareness to something requiring an evaluation, in order to avoid or affront a 
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potentially dangerous situation. The above-mentioned example could be useful again: if 
a driver hears a car horn, he orients its attention towards it in order to evaluate its source 
and everything else related (a dangerous, approaching car or a car in another route, 
honking to a distracted pedestrian). 
We recorded ERPs in our study since their use as a tool of cognitive performance 
evaluation. This recording technique is widely used in assessing cognitive performance 
in subjects suffering from Parkinson and Alzheimer diseases [39]. Moreover, metabolic 
state and appetite may interfere with P300 evoked related brain potentials thus affecting 
cognitive performance [40].   
Three dimensions define ERPs waveforms: scalp region, amplitude and latency. The 
scalp regions relevant for our study and depicted in figure are Frontal (FZ); Central (CZ) 
and Parietal (PZ) (figure 1.2a). According to several studies, which managed to separate 
P300 waveform components, to evaluate cognitive performance recording should occur 
in FZ scalp region [41]. Amplitude is the extent of neural activity and latency, measured 
in milliseconds (ms) is the point at which the amplitude of a particular waveform is 
maximum. As previously stated in this text, P300 waveform amplitude reaches its 
maximum between 250 and 350ms, thus the origin of the name.  
Relating to the previously described driver-car horn example it is easy to notice that not 
every external or “deviant” stimulus redirects the focus of attention: not every sound 
heard while driving is able to orient the attention from one focus to another. In fact, P300 
is not evoked by every external stimulus [42]. Throughout the first 100ms after stimulus 
exposure, an early activity exists. This activity, the mismatch negativity or MMN [42], 
reflects the fact that the brain has found something different, new or unexpected in 
between the normal stream of “standard” stimuli. MMN echoes the setting of a 
comparator mechanism.  
This machinery is evoked by every event capable of subtracting the focus of attention by 
the main task (e.g.: watching a movie, driving a car or reading a book) to the deviant 
stimulus. However, even if it is true that every deviant event may elicit a MMN 
comparator answer, it is not true that following every MMN the P300 occurs i.e.: not 
every deviant stimulus generates an orienting response. 
Gaeta et al. and Schröger [43-44] have firstly described this. Their evidences support that, 
in order to generate the following P300, MMN has to be sufficiently large. In other words, 
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the event responsible of MMN settling has to be sufficiently deviant from the 
environment. Furthermore, their studies put a light on another aspect of ERPs: MMN and 
subsequent P300 generation occurs only if the deviant stimulus is presented in-between 
the recurrence of repeating standard stimuli. In fact, MMN does not occur if the deviant 
provocation lays at the start of the experiment [45]. This underlines the fact that P300 is 
a response to something new experienced by the brain during a situation classified as 
“normal” or “standard”. These evidences reinforce the hypothesis that P300 is a reaction 
to new stimuli. 
In addition, and hence strengthening the former evidence, Sokolov et al [46] have 
demonstrated that the answer to deviant stimuli was no longer elicited after repeated 
presentation. This finding suggests a memory for the repeated events. The biological 
meaning of this adaptation finds partly explanation by the need to orient the attention only 
towards what is really new and deviant. 
One can use several experimental methods to evoke and then measure P300 waveforms. 
In a typical experimental set up, two classes of stimuli exists: the standard one and the 
deviant one. While the former is a repetitive stimulus to which the subject undergoing the 
measurement is exposed, the latter is the culprit of potential evocation and usually 
referred as “the oddball” event. The stimuli used can have different sources: visual, 
somesthestic or auditory [47-48].  
During these experiments, subjects follow a specific task while being exposed to the 
target stimulus. The task may be active, passive or novelty oddball. In active tasks, 
subjects receive instructions to count mentally the events or proposed stimuli.  
While performing passive tasks, volunteers’ attention is driven away from focus (e.g.: 
reading a book or watching a silent movie) by a deviant stimulus. In novelty oddball tasks, 
participants experience three stimuli with different frequencies: one high probability 
standard stimulus and two low frequency deviant ones. 
As tasks, stimuli belong to different classes as well: these stimuli can be somesthestic, 
visual or auditory. In our study, as in the majority of reported experiments [32-48-49], we 
used auditory stimuli. 
Studies prove that P300 waveform is impaired in patients showing lesions on the frontal 
or prefrontal region [50]. Other studies have subsequently proven via functional magnetic 
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resonance imaging (fMRI) that frontal scalp regions express P300. Due to the selective 
expression in frontal region of the scalp, we used for analysis FZ recorder potentials. 
Merging the evidence until now found in literature, the essential features that a particular 
stimulus has to have, in order to be able to generate an orientating response, are the 
following: 
 Unexpected; 
 New; 
 Unpredictable; 
 In-between something new or experienced. 
We used these characteristics to design the experimental protocol used in this study, 
which is an active task. Both the standard and the deviant stimuli were auditory. Material 
and methods section discuss standard/deviant ratio and the detailed protocol.    
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2a: schematic representation of the scalp region of 
interest during our P300 recording. FZ: Frontal Zone; CZ: 
Central Zone; PZ: Posterior Zone. For our purposes, FZ 
potentials were analyzed. 
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2. MATERIAL AND METHODS 
2.1 Subjects 
 We enrolled twelve volunteer subjects from “Università degli Studi di Milano” 
students or IRCCS Policlinico San Donato employees. The male to female ratio was 6/6; 
BMI and age were as follows: 22.2±1.5 Kg/m2 and 27±5 years old (mean ± standard error 
of the mean). 
All subjects were healthy and were eligible to access the study according to the 
inclusion/exclusion criteria presented in table 2.1a. To maintain the same metabolic 
profile during the duration of the study, each volunteer received instructions not to change 
his or her dietary lifestyle. Experimental protocol received positive consent by 
“Università degli Studi di Milano” Ethical Committee and informed written consent was 
obtained from each volunteer in accordance with Declaration of Helsinki guidelines. All 
procedures used complied with the Good Clinical Practice (GCP) principles. 
 
 
Table 2.1a: table reporting inclusion and exclusion criteria evaluated 
for this study. BMI: Body Mass Index; NHLBI: National Heart, Lung 
and Blood Institute; ADA: American Diabetes Association; ATP III: 
Adult Treatment Panel; NCEP: National Cholesterol Education 
Program. 
 
To establish the basal metabolic state of the subjects, they underwent a basal blood 
withdrawal to determine lipid basal profile (total cholesterol; LDL; HDL; triglycerides 
and free fatty acids), glucose and insulin plasma levels. We analyzed this profile during 
Inclusion criteria
Age 18-40 years old
BMI 18.5-24.9 Kg/m2 according to NHLBI
Stable diet
Exclusion criteria
Type 1 or type 2 Diabetes (ADA criteria)
Glucose intolerance (ADA criteria)
Dyslipidemia (ATPIII according to NCEP)
Metabolic Syndrome
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the first visit to asses study inclusion/exclusion. All subject tested for inclusion were 
eligible for the study, table 2.1b represents basal data. 
 
 
Table 2.1b: table representing basal data of the twelve subjects assessed 
for eligibility. HDL: High Density Lipoproteins; LDL: Low Density 
Lipoproteins; NEFA: Non-esterified fatty acids. 
 
After formal admission into the study, the subjects underwent two protocols: one, referred 
as protocol M to evaluate metabolic effects and ghrelin inhibition and one, referred as 
protocol N to measure evoked related brain potentials. Figure 2.1a  provides a schematic 
representation of study enrollment and design. Subjects participated to protocol M and 
protocol N in different days. The eight experimental days were separated at least by two 
weeks one from the other. 
2.2 Breakfasts’ composition 
 Breakfasts’ composition and nutritional facts are reported in tables 2.1c and 2.1d, 
respectively.  
 
 
Table 2.1c: table reporting the composition of the three commercial breakfasts tested. 
 
Mean SEM ±
Glucose (mg/dL) 84,6 1,9
Cholesterol (total) (mg/dL) 163,8 5,4
HDL-C (mg/dL) 63,3 2,3
LDL-C (mg/dL) 95,8 5,5
Triglycerides (mg/dL) 79,3 12,7
Insulin (uU/mL) 7,6 0,8
NEFA (mmol/L) 0,7 0,1
A B1 B2 B3
Glucose 50gr Milk 125mL Milk 220mL Milk 125mL
Corn Flakes 30gr Apple 200gr Apple 150gr
Chocolate cream sponge cake 30gr Hazelnut-chocolate cream 15gr
Bread 50gr
17 
 
 
 
Table 2.1d: table reporting the nutritional facts of glucose (A) and the tested 
breakfasts. B1) milk and corn flakes; B2) milk, apple and chocolate cream filled 
sponge cake; B3) milk, apple, bread, hazelnut-chocolate cream.  
 
 
 
 
 
Figure 2.1a: Volunteers’ enrollment and protocol allocation chart. No volunteer tested for eligibility was excluded. Every volunteer 
was allocated to protocol 1 and 2 and every data has been used for analysis.   
A B1 B2 B3
Kcal 190 170.5 329.2 350.5
KJ 795.5 724.8 1389.2 1481.2
Proteins (gr) 0 6.2 11 9
Carbohydrates (gr) 50 31.5 51.8 61.4
1 -Sugar (gr) 50 8.5 44.9 35.1
Lipid (gr) 0 2.2 9.5 8.3
1 -Lipid (gr) 0 1.4 4.7 3
18 
 
 
2.3 PROTOCOL M-Oral Glucose and Breakfast Test Load 
 To asses metabolic and hormonal profile each subject underwent a 50gr-OGTT and 
three distinct Breakfast Test Loads (BTLs), one for each meal tested.  
Subjects received instructions to fast overnight (̴12 hours) and to show up the day after to 
start the test, between 8:30 and 9:00 in the morning. After an acclimation time, adequate 
personnel inserted a cannula needle in the volunteer’s forearm and took a first blood 
sample (time -15’) consisting of two tubes: plasma and serum to test glucose, insulin and 
ghrelin hematic levels. 15 minutes after the first blood sampling, we took a second one 
(time 0) to have two basal data. Immediately after, volunteers drank the glucose diluted 
in aqueous solution or ate assigned breakfast within a given ten min time.  
Then they underwent serial blood samplings until the end of the two hours of OGTT or 
BTLs (15’; 30’; 45’; 60’; 75’; 90’; 120’). During each experimental day, the total amount 
of blood withdrawn from volunteers was about 58.5mL. After an acclimation time, 
subjects were able to leave. This routine, was repeated for glucose (A) and test meals B1; 
B2 and B3 in experimental days separated by ̴2 weeks. 
Blood samples were kept on ice until centrifugation, which occurred at 4° within one hour 
and a half after sampling. After centrifugation, samples were split in several aliquots and 
frozen at -80°C for ghrelin analysis and storage. Free-insulin was dosed by a highly 
specific 2-site monoclonal antibody-based immunosorbent assay (ELISA; Dako 
Diagnostics, Cambridgeshire, UK). Plasma ghrelin level (total) was measured through 
enzyme-linlked immunosorbent assay (ELISA, Merck Millipore, Darmstadt, Germany). 
As regarding immunosorbent technique, all samples were analyzed in duplicate, intra and 
inter assay variability were below 10%. Duplicate samples exceeding 10% CV, or 
samples which optical density (OD) did not fall between the linear range of the standard 
curve, were repeated.  
  
19 
 
 
2.4 PROTOCOL N-Cognitive processing of sensory information 
 Cognitive processing was assessed via the previously described P300 ERPs 
evaluation. As beforehand stated, the experimental set up used for our study was an active 
oddball task with auditory stimuli.  
The standard stimulus was a “beep” sound while the deviant or oddball one consisted of 
a pitched “beep” sound. The subjects had to follow a simple, active task i.e.: mentally 
counting the number of pitched “beep” sounds heard through an earphone set and report 
it to the researcher. 
Five electrodes were placed on the following scalp regions: the above-mentioned frontal 
zone (FZ); central zone (CZ); posterior zone (PZ) and A1-A2 regions. The latters, refers 
to Auricola zone 1 and 2, the left and right ear, respectively and served as signal stabilizer. 
FZ, CZ and PZ was instead used for signal recording. For further analysis, we used only 
FZ P300 latency. The electrodes were connected to neural machine Synergy (Lubiana, 
Slovenia). 
Subjects received instruction to fast overnight (̴12 hours) and to show up the day after to 
start the test, between 8:30 and 9:00 in the morning. After electrode placement, 
measurements took place with subjects sitting and keeping their eyes closed, in order to 
avoid visual stimuli.  
Each subject followed this routine on the same day: 
 Admission at the hospital 
 First ERPs recording 
 Assigned breakfast consumption within 10 minutes 
 Three hours waiting period 
 Second ERPs recording 
During both first and second Evoked Related Potentials recording, volunteers had to listen 
to repeated “beep” sounds (the standard event) and to mentally count different ones (the 
oddball event). In this occasion, oddball events were pitched “beep” sounds. The 
standard/oddball events ratio was 80/20%. We presented the oddball events in a 
randomized fashion, to keep the stimulus “new” and “unexpected”. 
To obtain a valid ERPs measurement and to avoid the influence of other external stimuli, 
subjects kept their eyes closed during P300 recording. 
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By excluding visual stimuli, we were certain that recorded P300 arose after experimental 
provocation only. 
This routine, was repeated for glucose (A) and test meals B1; B2 and B3 in experimental 
days separated by ̴2 weeks. 
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2.5 ELISA 
 Enzyme-Linked Immunosorbent Assay (ELISA) is a laboratory technique that 
spoils protein property to adsorb to plastic surfaces and antibody-antigen reaction. Thanks 
to this technique, it is possible to detect a specific molecule recognized by a specific 
antibody and to quantify it by utilizing a standard curve.  
ELISA can have different approaches in detecting the target molecule; the one used in 
this protocol is a sandwich-ELISA. This protocol aim is to form an antibody-antigen-
antibody complex, the “sandwich”, which can be detected via a streptavidin-Horseradish 
Peroxidase (HRP) complex. All reactions take place in a 96-flat bottom-wells microtiter 
plate, which is pre-incubated with an amount of specific antibody. 
In every plate, unknown samples, controls and standard are added. Controls are samples 
in which the target molecule is known and are used to verify the good quality of the assay. 
While the purpose of controls is to determine the quality of the experimental run, 
standards function is to generate the curve that will be used to obtain concentration values. 
Standards are, in fact, samples containing a specific amount of target molecule. These 
samples’ concentration varies from high to low following a specific dilution (e.g.: 1:10 
or 1:2). The OD read from these samples will be the reference to create a standard curve. 
The OD read from the unknown samples is then interpoled to standard curve to calculate 
the amount of target molecule in samples. Figure 2.5a summarize the protocol used.  
Each sample is co-incubated in duplicate with a biotinylated antibody to form the 
sandwich complex as seen in figure1. Subsequently, the most important step of ELISA 
procedure occurs i.e.: wash. This step is particularly critical since it allows the removal 
of unwanted molecules and the excess of antibody or reagents used during the protocol. 
Improper wash ends with inaccurate results, high CV% values or failure in color 
development. After a series of three washes with the wash buffer, HRP is added into the 
plate to bind to the biotinyated antibody. The excess of HRP is washed away with three 
washes. Again, this step is crucial to avoid improper results. The antibody-sample-
biotinylated antibody-HRP complex adsorbed to the micortiter plate is incubated with 
TMB. This molecule is the substrate of HRP, which starts catalyzing the colorimetric blue 
reaction. After an incubation time, the reaction is blocked by adding 2N HCl. 
The result is that blue color turns from blue to yellow and its intensity is proportional to 
the analyte present in the unknown sample. Via a reader, the micortiter plate OD is read. 
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A software builds the standard curve and, after samples’ OD interpolation, gives the 
unknown samples concentrations.     
 
Figure 2.5a: Schematic representation of sandwich ELISA protocol: 1) an amount of the unknown sample (red dots, triangles and 
diamonds) and of the specific biotinylated antibody are added into the well to incubate; 2) sample and antibody are then removed via 
several washes: 3) HRP (green) is then added into the wells to bond with biotinylated antibody (grey); 4) HRP excess is washed away; 
5) TMB substrate (blue dots) is added in order to start colorimetric reaction; 6) the reaction is then stopped with 2N HCl and 7) the 
plate is read at 450nm.  
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2.6 Area Under the Curve (AUC) 
 We used Area Under the Curve (AUC) to evaluate glucose, insulin and ghrelin 
excursions during OGTTs and BTLs. To calculate AUC we used the trapezoidal rule and 
the following method, described for OGTT, was used for every OGTT and BTLs. 
For each experimental day, time course data of glucose were collected and used to build 
a graph as shown in figure. The purpose of AUC method is to separate the whole area 
underneath the graph curve in trapezoids, calculate their area and sum it. To obtain the 
areas, the height of each trapezoid has to be multiplied by the sum of the basis of it and 
the result divided by 2.  
These dimensions are identified on the graph on y and x-axis: the height lays on x and it 
is the result of the subtraction (x1-x0) while the basis lay on y and are identified as y0 and 
y1.  Dimensions are depicted in figure 2.6a. 
 
 
Figure 2.6a: Area Under the Curve AUC formula dimensions representation: the data needed to calculate 
the area of the first trapezoid to the left are: the time interval between the two measurements given by the 
subtraction (x1-x0; 15-0); glucose concentration at time 0 (which is labelled as y0); glucose concentration 
at time 15 (which is labelled as y1). Height is labelled as “h”; b1 and b2 stand for base 1 and base 2, 
respectiveely. 
 
The sum of each trapezoid AUC gives total AUC. Incremental AUC 
was obtained by subtracting the AUC of the basal concentration 
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(calculated from minute zero to minute 120) from the total AUC (figure 
2.6b). 
 
Figure 2.6b: Area Under the Curve AUC formula dimensions representation: the data needed to calculate  incremental AUC. 
Basal AUC is obtained by using the depicted dimensions and it is represented by the red triangle. The result of subtracting 
basal AUC from total AUC is incremental AUC, which is the area in between basal AUC and the curve (green line). 
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2.7 Statistical Analysis 
 The comparison among studies was performed using within-subjects ANOVA with 
Greenhouse-Geisser correction followed by Dunnet’s post-hoc tests (A, glucose as 
control). Pearson’s correlation test and linear regression analysis were conducted between 
plasma ghrelin and FZ decrement.  
All data were represented as mean ± SEM. An α level of 0.05 was chosen as statistically 
significant. Analyses were carried out with the Statistical Package SPSS version 22 for 
Mac (Armonk, NY, USA; IBM Corp.), Excel 2011 (Redmond, WA, USA; Microsoft), 
GraphPad Prism 7 (San Diego, CA, USA). 
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3. RESULTS 
3.1 Metabolic Data 
 To evaluate metabolic profiles in the different breakfasts and in glucose, we assayed 
total ghrelin, insulin and glycaemic serum levels during OGTT and BTLs. All data are 
represented as mean ± standard error of the mean. Table 3.1a report all data. 
3.1.1 Glycemia 
 All subjects exhibited a similar and within normal range fasting plasma glucose 
(77±1.3 mg/dL). Glycemic curves for glucose and each breakfasts are depicted in. 
Glucose consumption alone displayed a greater augment in glucose plasma levels when 
compared to all three commercial breakfasts. This data is visually represented comparing 
the OGTT and the BTLs one with another (figure 3.1.1a); furthermore, the Area Under 
the Curve (AUC) for each experimental condition is significantly different from the 
control one (Repeated Measures ANOVA with Greenhouse-Geisser correction: 
p<0.0001).  
Dunnet’s post-hoc test revealed that: A and B1 AUCs were higher than B2 and B3 and 
all three commercial breakfasts differed in a significative fashion from glucose AUC, thus 
in a different way (AvsB1: p<0.05; AvsB2-3: p<0.01). 
Control glucose plasma level, reached a peak 30 minutes from ingestion had occurred 
(123.8±6.5 mg/dL). When breakfasts were compared to control, B2 and B3 showed a 
significantly lower augment in glucose plasma level 30 minutes after ingestion (86.5±4.6 
mg/dL; 92.2±5.1 mg/dL, respectively. P<0.05). B1 plasma glucose concentration 30 
minutes after ingestion was still lower than control (109.8±4.2 mg/dL) but not in a 
significant fashion. 
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Figure 3.1.1a: glycemia excursions graphs. Graphs 1-2-3-4 show comparisons between glucose OGTT (green line) and 
every breakfast test load. Graph 1: glucose vs B1 (cereal and milk); graph 2: glucose vs B2 (apple, milk, chocolate cream 
sponge cake); graph 4: glucose vs B3 (milk, apple, bread, hazelnut chocolate cream); graph 4: area under the curve 
(AUC) comparison. Repetead Measures ANOVA with Greenhouse-Geisser correction was significant (p<0.0001). 
Dunnet’s post-hoc test revealed that B1 (p<0.05) as well as B2 and B3 (p<0.01) had lower glucose AUCs than Control. 
(All data are represented as mean ±sem. *: p<0.05; **: p<0,01; ***: p<0,001 
 
3.1.2 Insulinemia 
 All subjects exhibited a similar and within normal range plasma insulin level 
(5.25±1.49 µU/mL) Plasma insulin levels obtained during experimental OGTTs and 
BTLs are represented in figure 3.1.2a. When compared with glucose, all tested breakfasts 
showed smaller insulin excursions.  
Repeated Measures ANOVA analysis between the four groups resulted to be significant 
(p>0.001). Dunnet’s post-hoc revealed that B1 and B2 (p<0.01), but not B3, had smaller 
insulin AUCs than control. 
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Figure 3.1.2a: insulinemia excursions graphs. Graphs 1-2-3-4 show comparisons between glucose OGTT (green line) 
and every breakfast test load. Graph 1: glucose vs B1 (cereal and milk); graph 2: glucose vs B2 (apple, milk, chocolate 
cream sponge cake); graph 4: glucose vs B3 (milk, apple, bread, hazelnut chocolate cream); graph 4: area under the curve 
(AUC) comparison.  Repetead Measures ANOVA was significant (p<0.001). Dunnet’s post-hoc test revealed that B1 
and B2 (p<0.01), but not B3 had lower insulin AUCs than Control. All data are represented as mean ±sem. *: p<0.05; 
**: p<0,01. 
 
3.1.3 Ghrelinemia 
 Plasma ghrelin was similar at baseline (415.5±5.2 pg/mL) in all subjects. After meal 
or glucose ingestion, 2-hour plasma ghrelin attained the lowest level in B3 (332±30.2 
pg/mL), but the decrement with respect to A (420.6±44.2 pg/mL) did not achieve 
statistical significance. Final plasma ghrelin inhibition (data obtained by simply 
subtracting the ghrelin value at 120 minutes to the one at 90 minutes) tented to be higher 
in B1; B2 and B3 groups with respect to A, without achieving significant differences 
among the four tests (Repeated Measures ANOVA). Figure 3.1.3a depicts ghrelin plasma 
levels during OGTT and BTLs. 
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Figure3.1.3a: ghrelinemia excursions graphs. Graphs 1-2-3-4 show comparisons between glucose OGTT (green line) and every 
breakfast test load. Graph 1: glucose vs B1 (cereal and milk); graph 2: glucose vs B2 (apple, milk, chocolate cream sponge cake); 
graph 4: glucose vs B3 (milk, apple, bread, hazelnut chocolate cream); graph 4: area under the curve (AUC) comparison. Repetead 
Measures ANOVA applied to the final (90-120 min) level of ghrelin (expressed as change with respect to the baseline) found no 
significant difference among the four groups.. All data are represented as mean ±sem.  
 
3.2 Electrophysiological data 
 Three hours after ingestion, all of the tested breakfasts displayed a FZ decrement 
with respect to control A (figure 3.2a). The incremental frontal P300 potential (obtained 
by subtracting the latency value pre-ingestion from the latency post-ingestion) showed a 
significant anticipiation only in B3 (-33.6±5.9ms) with respect to A (9.7±6.6ms). 
Repeated Measures ANOVA with Greenhouse-Geisser correction was significant 
(p=0.007) and Dunnet’s post-hoc test confirmed that B3 was the sole breakfast to display 
a significant FZ decrement compared to glucose (p<0.01). 
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Figure 3.2a: these graphs show, for each subject, P300 incremental after consumption (P300 value post-breakfast consumption minus 
P300 value before breakfast consumption). A positive difference between post breakfast and fasting P300 values (ms) indicates that 
P300 peak is postponed after breakfast consumption. A negative value stands for a peak anticipation. Repetead Measures ANOVA 
with Greenhouse-Geisser correction was significant (p=0.007). Dunnet’s post-hoc test showed that B3 was the only group to display 
a significant decrement of FZ with respect to Control (p<0.01). All data are represented as mean ±sem. *: p<0.05; **: p<0,01. 
 
3.3 Correlation and linear regression 
 Only breakfast 3 plasma ghrelin final inhibition and P300 FZ decrement (FZ 
latency value post breakfast consumption minus FZ latency value pre breakfast 
consumption) were positively correlated (P=0.01; R2=0.37; slope coefficient=1.964, 
figure 3.3a).  
 
Figure 3.3a: Linear correlation between final ghrelin inhibition (Y axis) and 
ΔP300 (X axys; ΔP300= difference bewteen P300 FZ value post consumption 
and P300 FZ value pre-consumption) after B3 ingestion.  
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Table 3.1a: table representing all data from OGTTs and breakfast test loads. All data are represented as media 
± standard error of the mean.   
Glycemic profile
0' 15' 30' 45' 60' 75' 90' 120'
A
Mean 77 106 124 123 109 98 94 82
SEM (±) 1 6 6 7 5 5 7 6
B1
Mean 76 88 110 99 94 91 88 84
SEM (±) 2 4 4 4 5 3 3 1
B2
Mean 77 95 87 77 70 75 79 81
SEM (±) 2 4 5 3 3 3 3 2
B3
Mean 76 98 92 82 81 83 85 86
SEM (±) 1 3 5 5 5 4 4 4
Insulinemic profile
0' 15' 30' 45' 60' 75' 90' 120'
A
Mean 5,6 25,3 37,0 43,6 37,8 29,3 27,3 12,6
SEM (±) 0,6 4,0 5,1 5,7 3,2 3,3 4,5 2,8
B1
Mean 6,1 20,5 33,3 25,4 21,8 16,8 15,0 7,8
SEM (±) 0,7 3,5 4,7 3,0 3,6 2,7 3,0 0,6
B2
Mean 6,4 39,5 36,3 21,9 15,6 16,8 14,6 11,8
SEM (±) 0,6 4,2 3,4 3,6 1,7 2,2 1,7 2,1
B3
Mean 6,0 36,8 35,8 22,5 22,5 20,0 21,9 17,7
SEM (±) 0,5 2,6 4,7 3,0 2,9 3,2 3,6 3,3
Ghrelin profile
0' 15' 30' 45' 60' 75' 90' 120'
A
Mean 415 431 402 393 404 385 393 421
SEM (±) 38 35 30 32 33 29 27 44
B1
Mean 417 410 347 346 371 358 392 419
SEM (±) 49 43 35 32 36 40 46 46
B2
Mean 405 378 338 328 339 354 379 382
SEM (±) 31 29 25 23 20 21 30 30
B3
Mean 369 368 342 318 321 322 331 332
SEM (±) 28 34 28 24 26 26 27 30
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4. DISCUSSION 
 Obesity rapidly became a health emergency, both in developed and in developing 
countries. Urbanisation, augmented or imbalanced food intake, sedentary life style, 
genetics and diseases affecting endocrinology system are the main culprits of this 
emergency. Amongst the range of different causes and therapies related to this disease, 
the aspects related to food properties are studied with greater and greater attention since 
they may hide positive or negative properties linked to obesity onset, speed-up or delay.  
Regular breakfast consumption is a helpful habit to control BMI, satiety and to obtain and 
maintain the correct level of attention during morning, especially for children and 
adolescents. While metabolic and hormonal profiles have been widely studied, breakfast 
consumption effects on attention and cognitive performance are reported indirectly by 
analysing school achievements and behavioural aspects. Compared to this, studies 
evaluating cognitive processing of sensory information of different breakfasts are still 
few. Furthermore, studies tend to show chronic effects of breakfast consumption, but little 
is reported on acute effects. To our knowledge, this is the first time in which a study 
evaluated metabolic, hormonal and neural aspects all together. 
Given the importance of breakfast in the daily food intake, in this study, we analysed how 
three commercial breakfasts when compared to glucose, differently affected metabolic 
response and cognitive performance via two well-known and characterised protocols: 
OGGT and evoked-related brain potentials monitoring [51]. The data we collected 
showed that those breakfasts are able to stimulate a lower glycemic response even if the 
tested breakfast had a greater carbohydrates content (as shown in table 2.1d). Notably, 
breakfast labelled as B3 showed the same glycemic pattern as B1 and B2, even if its 
carbohydrates content was greater.  
In accordance with glycemic profiles, insulinemia showed a similar trend. As depicted in 
figure 3.1.2a all tested meals were able to minimize insulin excursion. Keeping an eye 
on food intake and weight control, this is an aid in controlling hunger, since the reported 
effects of high insulin peaks on appetite [52]. 
Furthermore, ghrelin excursions data showed how these breakfasts had the tendency to 
inhibit total ghrelin secretion, thus maintaining satiety regulation. What is particularly 
relevant in support of the latter sentence is that ghrelin inhibition was stable during the 
whole OGTT. In addition, while control and B1 ghrelinemia plasma level after 
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120minutes was the same as the basal data (A: 415±38 vs 421±44 B1: 417±49 vs 419±46), 
meals B2 and B3 showed a tendency in lowering ghrelin plasma levels (B2: 405±31 vs 
382±30 B3: 369±28 vs 332±30) thus not in a significant fashion. These data suggest the 
importance of consuming breakfast with a blend in macronutrients in controlling satiety. 
If suggested in a controlled dietary life style, this kind of breakfast may help reduce the 
food and consequent caloric intake during lunch, helping the weight loss. A model of 
breakfast as the one proposed in meals B2 and B3, could be an ally in fighting scarce 
compliance of patients undergoing a restricted dietary life style or simply hale and hearty 
individuals willing to follow an healthier diet. In fact, the consumption of high-palatable 
foods could enhance satisfaction and adherence to dietary life styles.  
The control on insulin and the tendency to inhibit ghrelin exerted by tested breakfasts can 
certainly help and maximise this aspect. Furthermore, ghrelin is responsible not only for 
the quantity of food ingested, but also for its quality. High ghrelin plasma levels can lead 
to prefer aliments with high content in fat and energy intake [26]. As reported before, 
ghrelin functions go beyond appetite triggering and food carving. Since this hormone 
promotes adipogenesis and lipogenesis [27], a better inhibition can be helpful in 
preventing gain weight and the related consequences. 
The electrophysiological results found in this work on acute effects, demonstrated that 
B3 breakfast was able to anticipate significantly P300 peak latency. Since P300 latency 
reflects the amount of time an individual needs to compare the deviant stimulus received 
with the standard ones and to shift its attention, the peak anticipation occurred after 2 
hours from B3 ingestions (-33.9±5.9ms) reflects an improved cognitive performance 
when compared to glucose. The presence of hazelnut and chocolate in B3 meal has to be 
taken in account due to the presence of macronutrients of which both aliments are rich 
[53-54]. These macronutrients are methylxanthines and flavonoids. Xanthines, which also 
are a product of from caffeine metabolism, have effects on cardiovascular system, 
improving vascular function and lowering blood pressure [55]. Furthermore, they are able 
to cross the hematoencephalic barrier and binds to adenosine receptors, influencing 
arousal, mood and concentration [56]. Flavonoids, on the other hand, are thought to 
ameliorate neural activity by acting on blood flow and/or oxygen consumption [57]. 
As previously reported in literature, regular breakfast consumption is associated with 
better outcomes in school achievements and children behaviour [11]. A wide range of 
studies reported that poor nutritional status disturbs brain functionality [58-59] but even 
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if it is known that breakfast skipping is an unhealthy habit, more and more people keep 
skipping it. In this scenario tendency to inhibit ghrelin and breakfast composition are 
again advocated: since ghrelin may mediate reward responses to food, it’s inhibition the 
consequent satiety regulation and the related reward feeling may contribute in fighting 
scarce compliance in following a healthy diet style. The reward effect from eating 
something palatable and the awareness of “being more attentive” that individuals may 
experience after chronically consuming a particularly designed breakfast, may also 
potentiate this aspect. 
Alongside these considerations on the interplay of ghrelin inhibition and P300 evoked 
related brain potential, only in B3 a significantly association between final ghrelin 
inhibition and P300 peak anticipation was found. Even if the association cannot make us 
suggest that ghrelin inhibition and P300 peak anticipation are in a causal relationship, it 
is true that meal B3 elicited more desirable responses, from metabolic and 
neurofunctional profile. 
All tested breakfasts (B1, B2 and B3) induced lower glycemic responses and AUCs when 
compared with glucose. Meal B1, composed by corn flakes and milk, elicited the highest 
one thus not in a significant way. This feature could suggest that the higher amount of 
carbohydrates present in B2 and B3 was not deleterious in respect to glycemic responses. 
Another desirable facet showed by tested breakfasts is that insulinemic AUCs were 
contained with respect to control (see). Thus not significant, this tendency is desired due 
to the above-mentioned effects of high insulinemic levels, which may possibly trigger 
hunger and promote adiposity.  
In conclusion our findings, new both in their integrative approach and the analysis of 
acute effects, strengthen the message of the importance of the first meal of the day. 
Consuming a well-balanced breakfast is a helpful tool to prevent gain weight and the 
subsequent dramatic consequences and to go through morning day-life challenges that 
require active attention and focus.  
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5. EU-China Partnership on Novel Strategies to Treat Diabetes from 
Plant-derived proteins (ECRIP) 
 5.1 Introduction 
 During the last months of my doctorate fellowship, I had the opportunity to study 
at the Sixth’s People Hospital affiliated with Jiao Tong School of Medicine of Shanghai. 
The purpose of this project, founded by European Union Delegation of China and 
Mongolia, is to develop novel approaches to diabetes management via the usage of 
nutraceutics normally found in ingested food and to study the differences between Han 
population, the biggest among 56 Chinese ethnic groups, and Caucasians [60].  
Literature regarding nutraceutical aspects of particular macronutrients found in edible 
vegetables or fruit is growing so much that lectures on pathological and physiological 
effects of some molecules are now scheduled in national and international congresses 
regarding treatment of obesity and even diabetes. The team I had the chance to work with 
during these years, as a notable example of the importance of this subject and its concern, 
detains a patent of nutraceutical effects of conglutin-γ, a protein found and extract from 
lupin, on insulin resistance. This is an example showing that researchers, alongside the 
effects shown in clinical field, want to know what happens in a deeper, molecular level. 
These substances are important for a particular set of reasons: the law and the long, 
complex process regarding the commercial emission of foods and nutraceutical 
substances are not as strict as the ones regarding a new treatment or drug. For the above-
mentioned reason, they are readily and quickly available for market and more accessible 
to people. Additionally, the fact that these molecules are found in common foods known 
and maybe appreciated more by patients or healthy individuals may help compliance to 
treatment. 
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5.1.1 Diabetes in Asia 
 Diabetes prevalence rose during the past years all over the world. Recorded number 
of 180 million patients in 1980 reached the dramatic 420 million peak in 2014, as reported 
by World Health Organization (WHO, 19).  Developing countries are facing rapid 
urbanization and modernization rates and predictions are for them to display the highest 
incidence and prevalence of diabetes [61]. Amongst these countries, India and China 
share the major number of subjects with full-blown diabetes or prediabetes [61] and 
estimations are that these countries will share the highest number of diabetic patients 
worldwide [62].  
In China, on which ECRIP project focuses, during past decades rapid modernization and 
urbanization occurred, helping obesity spread. To give an idea of how quickly this process 
occurred in China, the percentage of urbanization in China rose from 27.4% in 1990 to 
44.9% in twenty years span [63]. Urbanization and modernization had a strong impact on 
Chinese population habits since they led to migration phenomena from rural areas to 
cities. The migration from rural areas to metropolis and modelling their life style to a 
more globalized one resulted in an augment in physical inactivity and in BMI, increasing 
overweight, obesity and diabetes [64]. 
However, the actors that led to increase in obesity and diabetes are not urbanization and 
modernization only. In fact, Chinese behavioral habits helped type 2 diabetes mellitus 
upraise. Eating has several meanings for Chinese culture, Han population views food 
consumption and sharing in context of social bonding and interaction, often involving 
close friends and family members. [65] Chinese population are known for eating in 
groups and foods are designed and cooked to be eaten communally, thus leading to the 
spread of rich banquets as a way to consume food. These banquets may help an 
unhealthy and imbalanced nutrient and caloric intake.  
Alongside socio economic ones, some other features exist: Asian populations seem to be 
more prone in developing features related to diabetes onset. In fact, they show insulin 
resistance and MetS features (hypertriglyceridemia; increased abdominal or visceral fat) 
starting from young age, even if obesity is absent [66 ̴ 69]. Strengthening these aspects, 
when compared to Western patients, Asian populations show the tendency to develop 
diabetes earlier [70].  
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While sharing the same dramatic rise in diabetes incidence, Asian and Caucasians diabetic 
patients’ clinical features are not exactly the same. In literature, several studies report the 
differences between clinical features of type 2 diabetes mellitus in Asian populations 
when compared to Caucasians [70]. Asians suffering from diabetes are more prone to 
develop micro and macroalbuminuria when compared to Caucasians [71-72].  
Furthermore, Asian patients are more prone to suffer from proteinuria, retinopathy, 
microalbuminuria and macroalbuminuria (45%,57%,40% and 60%, respectively) when 
compared to Caucasians (29%, 28%,29%, 40% and 60%) [70].  
Also differences in genetic factors subsist. As an example, the protective effect on insulin 
resistance exerted by proliferator-activated receptor-γ (PPARG) rs1801282 SNP 
(Pro12Ala) seen in Western population was not reported regularly in Eastern ones [73]. 
Another SNP, related to T2DM development is rs7903146 on transcription-factor-7-like 
protein 2 (TCF7L2). However, this risk factor is not associated with T2DM in Asian 
populations. [74-75]. 
The example reported, is well explained by a monogenic form of diabetes: Maturity Onset 
Diabetes of the Young (MODY). Subjects affected by this particular disease are 
characterized by a young age at onset (usually <25 years old), are insulin independent, 
have first-degree relatives suffering from diabetes and lack specific Type 1 Diabetes 
Mellitus antibodies. Furthermore, in contrast with T2DM, BMI falls within normal range 
[76].  
Different genes are associated with different MODY types onset. While in Caucasian 
populations MODY3 and MODY2, cover for the 80-85% of this particular diabetes cases 
[77], studies conducted in Asian countries give totally different results: as an example, a 
study conducted on 146 unrelated clinical MODY families in Hong Kong found out that 
MODY3 and MODY2 prevalence was 9 and 1% respectively [78].  
These evidences highlight the differences existing between Chinese and Caucasians 
diabetic patients both in clinical features, complications, and in polymorphisms (SNPs), 
for these reasons, part of the project is to apprehend adequate and standardised protocols 
to characterize the population studied, in order to compare them properly and define better 
the outputs of the research. As part of ECRIP programme, my main aim was to understand 
and become confident with molecular biology techniques such as sequencing. The 
protocol I have learned will be discussed further in this thesis.  
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6 MATERIAL AND METHODS 
6.1 Sanger’s Reaction 
 The main aim of my internship in Shanghai was to learn molecular biology 
techniques in DNA extraction, amplification and sequencing via Sanger’s reaction. 
Sanger’s sequencing reaction, developed in 1977, is the basis of the First-Generation 
Sequencing (FGS) laboratory equipment [80]. This technique is to date the gold standard 
for detecting unknown mutations in specific DNA Regions of Interest (ROI). The 
rationale of this protocol is to introduce dideoxynucleotides (ddNTPs) into a DNA 
synthesis reaction. These ddNTPs lack a hydroxyl –OH group in 3’position and their 
inclusion in the DNA strand blocks further synthesis by DNA polymerase [80]. 
If, for instance, a DNA template undergoes amplification with a traditional PCR mix 
containing primers, ions, MgCl2, DNA polymerase and deoxynucleotides (dNTPs), the 
whole ROI comprised in between the primers will be synthetized. However, if a 
traditional PCR mix contains ddNTPS-A (dideoxynucleotides Adenine), every amplicon 
synthesis will be randomly blocked at -A positions during strand elongation, generating 
a mixture of DNA fragments, with different lengths.  
It is possible to read and analyse the sequences of ddNTPS-A bases on these fragments 
using denaturating acrylamide gel. This is due to the different length of the amplicons and 
to the high separating power of the acrylamide net. If every base follow the same protocol, 
it is possible to read the whole ROI. 
During the following years, and after the introduction of Polymerase Chain Reaction 
(PCR) by Kelis Mullis, companies and researchers developed new techniques and 
technologies to obtain better and faster sequencing results. Accompanied by this vision, 
market saw the introduction of automated sequencers and new chemistries. Between the 
several different protocols now available to sequence a particular ROI, the one I used 
relays on dye terminators chemistry. 
This protocol differs from the original one since the reaction mix used contains every 
ddNTPs, avoiding the usage of four different mixes for one sample. Four different 
fluorochromes label the four different ddNTPs, so that every base is associated with a 
specific fluorescence. Thanks to this, it is possible to generate, in one single reaction tube, 
differently labelled amplicons with different lengths, according to the random inclusion 
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of marked ddNTPs during the synthesis process lead by DNA polymerase. Figure 6.1a 
gives a schematic representation of the protocol rationale. 
The sample is then analysed via dedicated equipment to generate an electropherogram as 
shown in figure 6.1b. 
Samples, running on a polymer gel, generate the electropherogram. As during a standard 
electrophoresis, PCR products run through the gel according to their length (short 
products run quicker than the longer ones, since they easily cross the net created by the 
gel polymer) and specific detector records their fluorescence and translates it into peaks, 
writing ROI sequence.  
DNA sequencing is a multistage technique and to get meaningful and trustful results, 
several steps must precede sequence analysis. The steps that will be discussed in detail 
later are DNA extraction, Region of Interest amplification, purification, proper Sanger’s 
reaction, purification and reading. 
 
Figure 6.1a: schematic representation of Sanger’s Reaction with terminal dye chemistry. DNA template (long blue line), previously 
amplified via classical PCR, undergoes another PCR cycle with forward or reverse primer (short blue line), DNA polymerase, dNTPs 
and fluorochrome-labelled ddNTPs (1). During this step in which DNA polymerase bounds to hybrid template and primer, starts 
elongation (2). While synthetizing the new DNA strand, the enzyme randomly picks up dNTPs or ddNTPs (3). If a dNTP is added to 
the sequence (3-left), the enzyme continues elongation. Inversely, if a ddNTP is added the synthesis reaction stops (3-center, right). 
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This generates a series of amplicons different in length and labelled according to the last base added (4) After Sanger’s reaction, 
samples undergo a gel electrophoresis in dedicated equipments, which read the length and fluorescence of each amplicon fragment 
and give as a result an electropherogram (5).  
 
 
Figure 6.1b: an electropherogram. The software reads amplicon fragments as they pass by during electrophoresis and renders their 
fluorescence as peaks. The result is the sequence of the region of interest. Each colour is matched with a different nucleotide (arrows). 
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6.1.1 DNA Extraction 
 DNA extraction is a crucial step in sequencing reaction analysis, since maximum 
purity and quality are mandatory features in order to obtain a fully readable 
electropherogram. To extract DNA, a standard commercial kit is used: QIAGEN DNeasy 
kit code 69054. 
The above-mentioned kit spoils a patented column method to extract DNA from cells and 
elute it. The sample used is the buffy coat generated after centrifugation of peripheral 
blood collected in vacutainer tubes containing EDTA. The presence of EDTA as 
anticoagulant prevents subsequent amplification reactions inhibition. 
This extraction method is quick, allows the manual processing of several samples at the 
same time, and is summarised in figure 6.1.1a. The cellular components of buffy coat are 
firstly lysed thanks a brief vortexing and incubation with proteinase K. The lysate is then 
mixed with ethanol and transferred to the spin columns.  
The column then undergoes three centrifugations steps with different buffers in order to 
wash out impurities and proteins. The final step is an elution in a small amount of 
Nuclease-free water (from 20 to 50µL). 
After this extraction, samples’ quantity and purity is observed trough spectrophotometer 
analysis. In fact, if the sample is old, stored in bad conditions or poorly extracted, the 
quantity may be affected. Furthermore, during the extraction process, extraction reagents 
(especially ethanol and isocyanil guanine) may pollute DNA and interfere with later 
protocols. 
The spectrophotometer generates a light beam at different wavelengths (280nm, 260nm, 
230nm) that pass through the sample, reads the different absorbance levels, expressed in 
optical densities (OD) and uses them to calculate DNA quantity and pollution: 
-A280nm: the software utilises the general rule that 1 OD corresponds to 40ng/µL of 
DNA and adjusts it by a specific distance correction factor to obtain DNA concentration. 
-A260nm: this value is used to verify the presence of proteins in the eluted samples. The 
ratio between A280 and A260 gives us a value that must fall within 2-2.10, thus indicating 
a sample containing DNA only 
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-A230nm: thanks to this, it is possible to state whether the sample pollution by ethanol, 
isocyanil guanine or other agents occurred. The ratio between A280 and A230 must fall, 
again, within a 2-2.10 range. The lower the value obtained, the more polluted is the 
sample. 
Samples failing to meet these conditions need to be extracted again, since further 
reactions may be influenced. 
 
Figure 6.1.1a: representation of experimental protocol 
used to extract DNA from blood samples.  
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6.1.2 Region Of Interest Amplification 
 To sequence correctly the region of interest, it is important to fragment it virtually. 
The sequencing reaction must have an amplicon which is no longer than 500bp, so it is 
necessary to design different set of primers able to cover all the sequence of interest.  
Another important aspect of primer design is that after sequencing reaction has occurred, 
due to interferences, roughly from 50 to 100bp at the beginning of the amplified region 
are usually lost. To avoid loss of information, primers should hybrid to genome 50 to 
100bp before actual ROI. A sample of a single exon gene is reported in figure 6.1.2a. 
 
 
Figure 6.1.2a: A hypothetical gene composed by one exon (dark green rectangle) is virtually fragmented by three set of primers: red) 
set one; yellow) set two; orange) set three. Primers have to be placed in order to cover all the region of interest. Note how the three 
sets overlaps and that set one and set three fall outside the region of interest (small light green rectangles).  
 
Samples then undergo a standard PCR cycle, according to the polymerase enzyme used 
and the melting temperature of each primer set (figure 6.3b).  
 
 
 
 
 
Figure 6.3b: PCR protocol used. Tann: Annealing temperature; Text: 
extension temperature. Tann has to meet the requirement of the specific 
primers set used, while Text matches the needs of the DNA polymerase 
used. 
As DNA sequencing requires high starting material quality and purity, it is binding to 
check the amplification via electrophoresis on acrylamide gels. Frederik M et al describe 
the standard protocol used to synthetize acrylamide gels and run samples in Current 
Protocols in Molecular Biology [81]. This process allows to visually identify the 
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amplicons produced during PCR reaction comparing the bands with the ones obtained by 
a simultaneously ran molecular weight. This sample generates a “ladder” of bands of 
known length. The criteria used to validate ROI amplification were: 
- amplified length in accordance with expected length; 
- presence of only one band 
 Fulfilling the above-mentioned conditions allow certifying the accuracy of the 
amplification and its purity. Furthermore, it is possible to check the presence/absence of 
unwanted amplified regions and adjust PCR conditions accordingly.  
As for DNA extraction, only samples that go on to the next stage: purification.  
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6.1.3 Amplicons Purification 
 After PCR amplification products validation via gel electrophoresis, the successive 
step is purification. In fact, after the first PCR, amplicons are diluted in the reaction mix 
used for the first PCR. This mix contains unused dNTPs, magnesium, primers, other 
buffer ingredients and ions. Since the presence of these factors can nullify further 
sequencing reaction, purification is needed. 
To do this, several commercial kits are available. The protocol does not differ from DNA 
extraction and purification one above-described since the purpose is to hold DNA in a 
membrane while the unwanted buffers, salts or molecules are washed away by 
centrifugation steps. 
The protocol used is from the commercially available kit from LIFEFENG code DK404-
02. Following the protocol provided with the kit, appropriate wash buffers are added all 
together to PCR amplification product to a spin-column membrane, which undergoes 
subsequent centrifugation steps. 
Finally, Nuclease-Free water is added to the column which is centrifuged, in order to 
release the copies of amplified DNA. 
At this stage, amplified samples are suitable for the next step, which is the actual Sanger’s 
sequencing reaction. 
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6.1.4 Sanger’s Sequencing Reaction 
 During this modified PCR protocol, each sample is assigned to two reaction tubes, 
for forward primer and reverse one. Forward and reverse primers separate amplification 
has some advantages.  
Firstly, each fragment amplified on one primer can be read on the other one thus allowing 
confirmation of variations in genome. Secondly, the amplification of both forward and 
reverse primer in the same tube leads to the presence of amplicon fragments of the same 
length but belonging to different regions of the tested sequence. Co-presence of these 
fragments in the tube generates inconsistent and mixed data, thus the need to separate 
forward and reverse reaction.  
 An appropriate reaction mix is prepared to the purpose. The mix contains the typical 
dNTPs, enzyme, ions and buffers of PCR reaction but with two main differences: the 
presence of ddNTPs labelled with fluorochromes and the usage of a single primer 
(forward or reverse) instead of the usually combined set. 
 The samples are added to the mixes and undergo PCR cycles to synthetize amplicon 
fragments, according to the specific features of DNA polymerase enzyme used.  
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6.1.5 Second Amplicons Purification  
 The final step before fragments reading is another purification. Even if samples end 
their amplification steps after Sanger’s reaction, the presence of enzymes and unused 
labelled ddNTPs interferes with sequence reading. 
This step differs from the first purification and relays on BigDye XTerminator® 
Purification kit (ThermoFisher Scientific, code 4376486) technology. The purifying 
solution is a mixture that allows the isolation of the above-mentioned unwanted mix 
remaining and fragments stabilization. The mixture, composed by two reagents 
(XTerminator™ Solution and SAM™ Solution) captures unused ddNTPs and buffer from 
the post-sequencing reaction and stabilizes the sample for subsequent reading. 
Samples are added at the bottom of a 96 multiwell plate, and according to kit instructions, 
in each well are added 45µL of SAM™ Solution and 10µL of XTerminator™ Soltuion. 
The plate is then covered with an adhesive film and undergoes vortexing for 30 minutes, 
in dark environment. This allows the reagents to free the solution from unused ddNTPs 
and buffers. After that, the plate is centrifuged briefly and analysed on dedicated 
instruments for electrophoresis and reading. In this case, Applied Biosystems 3500xL 
Genetic Analyser was used (ThermoFisher Scientific). 
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6.1.6 Sequence Reading and Analysis  
 After the sample run into the polymer amplicons lengths and fluorescence, which 
are read through detectors, are translated into peaks (figure 6.1b) in an electropherogram. 
Before reading, the electropherograms produced undergo a quick screening to assess their 
quality. Figures 6.1.6a provides an example of electropherograms with different quality 
levels. Only results allowing unambiguous reading have to be analysed. In fact, the 
presence of mixed peaks invalidates proper analysis (figure 6.1.6a, panels B-C). Samples 
failing quality control needs to be repeated. 
Good quality samples are read by scrolling the sequence, from left to right and looking 
for double peaks figure 6.1.6b gives an example of how a heterozygous SNP/mutation 
presence emerge. In this way, it is possible to screen the sequence for heterozygous 
alterations only.  
To obtain data on homozygous alterations, insertions or deletions we use dedicate 
software. They allow the comparison between the sequence to analyse and a reference 
one by aligning them and reporting lack of bases, insertions, deletions or homozygous 
SNPs/mutations. The reassuring presence of software able to read and compare sequences 
must not be overrated, in fact, only a trained eye can assess electropherogram quality and 
distinguish between real peaks and disturbances in a proper manner. 
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Figure 6.1.6a: Different reading analysis outcomes. Panel A shows a good quality electropherogram, 
since peaks are divided and the sequence can be read clearly. Furthermore, the absence of background 
disturbances allows determining the presence/absence of heterozygous peaks. Panel B shows this 
characteristic: the presence of disturbance peaks (black arrows) make it impossible to determine the 
presence/absence of heterozygous peaks. Disturbances may be so severe that the whole sequence is 
impossible to read (panel C).  
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Figure 6.1.6b: SNP variation read on an electropherogram. Panel A 
shows a 5’-3’ strand carrying a heterozygous SNP on position G. 
Differently from the previous well defined peaks, the third one is 
mixed with another one, proving the presence of two different bases 
on that position. Panel B shows the same SNP, of the same proband, 
on 3’-5’ strand. The simultaneous presence of the same SNP on both 
strands validates it. 
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7.1 DISCUSSION 
 
 Sequencing become during past years a toll to diagnose and discover diseases, to 
study populations genetic and to characterize specific aspects of patients and healthy 
individuals. 
During the internship in Shanghai, I had the chance to become confident with First 
Generation Sequencing and to gather the required skills to do and validate such 
experiments. 
While powerful and adaptable, this molecular biology protocol needs high 
standardization in every step, since the output of the final reading and analysis relays on 
the quality of previous stages. A poor DNA extraction, for example, can lead to failed 
PCR amplification and imprecise primer design is mandatory to reach reliable results. 
Furthermore, skipping amplicons purification between stages can affect subsequent 
reactions and reading. 
For these reasons, it is important to recognize what could have gone wrong while looking 
at a poor or failed electropherogram. An accurate analysis of the latter can tell a lot about 
the quality of the stages and may help troubleshooting: in fact, different systematic or 
random errors lead to different electropherograms.  
If the electropherogram is composed by several, high peaks, overlapping one with 
another, chances are that the mix contained both forward and reverse primer and not just 
only one. If peaks are extremely high, out of the detection range of the instrument, the 
amount of initial DNA was probably too high, so one should check extracted DNA 
concentration and dilution. 
Repeated, medium-high peaks could be interferences due to poor purification system. 
These peaks are particularly tricky because their fluorescence value can be as high as 
normal peaks and the software may mistake them for actual peaks. In this situation, 
further analysis to screen for insertion or deletion, will lead to dramatic false positive 
results.  
Even the position of failed samples needs attention; when different samples, performed 
on different runs but in the same well give negative results, the capillary system can be 
damaged, expired or poorly placed on the instrument. Case in point of the amount of 
elements that can generate a poor quality electropherogram.  
Though leading to further costs due to the repetition of the analysis, and that a good result 
is the main aim of sequencing reaction, the information given by an unsatisfactory 
electropherogram may be at least as useful as the one given by a good one. Thorough 
accurate troubleshooting analysis it is possible to act on the aspect that led to failed result 
maybe revealing a step in the protocol that should be reviewed. This allows to keep going 
towards cleaner and clearer results. 
Even if softwares are necessarily in sequencing analysis, they still lack the artificial 
intelligence needed to discern between peaks and disturbances, for example. The only 
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means to assess the quality of a good run and to evaluate critical points is the trained 
human eye. 
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